Evidence map›Paper›PMID 26289681›Full record

Trial reportJournal of the American Geriatrics Society2015

Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study.

Sascha Dublin, Rod L Walker, Shelly L Gray, Rebecca A Hubbard, Melissa L Anderson, Onchee Yu, Paul K Crane, Eric B Larson

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Geriatrics Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07510373 (Opioid Tapering After Hospital Discharge), which is not on this map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07510373 narecruitingnot on this mapstarted 2026, after this paper: background citation

Opioid Tapering After Hospital Discharge: Testing an Intervention to Improve Post-operative

TypeinterventionalSponsorMontefiore Medical CenterRan2026 to 2028Enrolled42ConditionsOpioid TaperingArmsTreatment as Usual (TAU), Telephonic Support (TS) Providers, DOTS Intervention
3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. A Qualitative Study of the Effects of Opioids on Chronic Pain, Function, and Cognition in Community-Dwelling Older Adults.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2025
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Innovations in pharmacovigilance studies of medicines in older people.British journal of clinical pharmacology · 2025
    Review
  15. Medication Exposure and Risk of Dementia and Alzheimer's Disease.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sascha DublinGroup Health Research Institute, Seattle, Washington.
Rod L WalkerGroup Health Research Institute, Seattle, Washington.
Shelly L GraySchool of Pharmacy, University of Washington, Seattle, Washington.
Rebecca A HubbardCenter for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Melissa L AndersonGroup Health Research Institute, Seattle, Washington.
Onchee YuGroup Health Research Institute, Seattle, Washington.
Paul K CraneDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington.
Eric B LarsonGroup Health Research Institute, Seattle, Washington.

Funding

Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
Opioids and the Aging Brain: Dementia, Cognitive Decline and NeuropathologyR03AG042930 · NIA · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI DUBLIN, SASCHA · 2012 to 2013
$156k
NIA NIH HHS R03 AG042930NIA NIH HHS R03AG042930NIA NIH HHS U01 AG006781NIA NIH HHS U01AG006781
6 · The paper itself

Abstract

objectivesTo determine whether prescription opioid use is associated with higher dementia risk or greater cognitive decline.

designProspective cohort study.

settingGroup Health, an integrated healthcare delivery system.

participantsCommunity-dwelling individuals aged 65 and older without dementia with at least 10 years of Group Health enrollment at baseline (N = 3,434; median age 74). MEASUREMENTS: The Cognitive Abilities Screening Instrument (CASI) was administered every 2 years. Low scores triggered detailed evaluation, and a multidisciplinary committee assigned dementia diagnoses. From computerized pharmacy data, cumulative opioid exposure was defined as total standardized doses (TSDs) dispensed over 10 years (excluding the most recent year because of possible prodromal symptoms). For comparison, use of nonsteroidal anti-inflammatory drugs (NSAIDs), characterized similarly, was examined. Dementia risk was analyzed using Cox proportional hazards models and CASI trajectory using linear regression models and generalized estimating equations.

resultsSeven hundred ninety-seven participants (23%) developed dementia over a mean follow-up of 7.3 years; 637 (19%) had possible or probable Alzheimer's disease. For cumulative opioid use, the hazard ratios (HRs) for dementia were 1.06 (95% confidence interval (CI) = 0.88-1.26) for 11 to 30 TSDs, 0.88 (95% CI = 0.70-1.09) for 31 to 90 TSDs, and 1.29 (95% CI = 1.02-1.62) for 91 or more TSDs, versus 0 to 10 TSDs. A similar pattern was seen for NSAID use. Heavier opioid use was not associated with more-rapid cognitive decline.

conclusionPeople with the heaviest opioid or NSAID use had slightly higher dementia risk than people with little or no use. These results may reflect an effect of chronic pain on cognition or residual confounding. Although opioids have other risks, little evidence of long-term cognitive harm specific to opioids was found.

Indexed as

Risk AssessmentAgedAged, 80 and overAnalgesics, OpioidCognitionCognition DisordersDementiaDose-Response Relationship, DrugFemaleFollow-Up StudiesHumansIncidenceMalePainPopulation SurveillancePrescription DrugsAnalgesics, OpioidPrescription Drugschronic paincognitive declinedementianonsteroidal anti-inflammatory drugsopioids

Identifiers

PMID26289681
PMCPMC4776316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.